EU
Commission takes first step towards adoption of a #PharmaceuticalStrategyForEurope
As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission has published a road map, inviting interested citizens and stakeholders to share their views on the Strategy. Scheduled to be adopted before the end of the year, the overall objective of the Pharmaceutical Strategy for Europe is to help ensure Europe's supply of safe and affordable medicines and support the European pharmaceutical industry to remain an innovator and world leader.
Health & Food Safety Commissioner Stella Kyriakides said: “By the end of the year, I will present an ambitious Pharmaceutical Strategy for Europe to ensure affordability, sustainability and security of supply. The coronavirus pandemic has showed us more than ever that we need to have a crisis-resistant system and the means to produce medicine within the EU to ensure timely access to essential medicines for our citizens and hospitals in all circumstances.”
Citizens, experts and stakeholders are invited to give, until 7 July 2020, their feedback to the road map through the Better Regulation Portal and consult the dedicated website for additional information and to follow updates. This road map will be followed by a public consultation.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
